Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 123.88 +0.01 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.87 | 52 Week High | $81.50 | |||
| Open | $122.89 | 52 Week Low | $66.33 | |||
| Day High | $124.11 | P/E | 49.16 | |||
| Day Low | $122.09 | EPS | $2.52 | |||
| Volume | 27,760 | |||||
| (NASDAQ: MIST) | Delayed: 0.80 +0.01 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $ | |||
| Open | $0.78 | 52 Week Low | $ | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.78 | EPS | $ | |||
| Volume | 138,018 | |||||

